Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia A Randomized, Double-Blind, Placebo-controlled Trial

Criner, G. J., Lang, F. M., Gottlieb, R. L., Mathews, K. S., Wang, T. S., Rice, T. W., Madduri, D., Bellam, S., Jeanfreau, R., Case, A. H., Glassberg, M. K., Lyon, G. M., Ahmad, K., Mendelson, R., DiMaio, J. M., Tran, M. P., Spak, C. W., Abbasi, J. A., Davis, S. G., … Lowry, S. (2022). Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine, 205(11), 1290–1299. https://doi.org/10.1164/rccm.202108-1859oc
Authors:
Gerard J. Criner
Frederick M. Lang
Robert L. Gottlieb
Kusum S. Mathews
Tisha S. Wang
Todd W. Rice
Deepu Madduri
Shashi Bellam
Robert Jeanfreau
Amy H. Case
Marilyn K. Glassberg
George Marshall Lyon
Kareem Ahmad
Robert Mendelson
J. Michael DiMaio
MaryAnn P. Tran
Cedric W. Spak
Jamil A. Abbasi
Steven G. Davis
Shekhar Ghamande
Steven Shen
Lisa Sherman
Simon Lowry
Affiliated Authors:
Frederick M. Lang
Columbia Affiliation:
Subjects:
COVID-19 Drug Treatment (MeSH)
Author Keywords:
covid-19
gm-csf
sars-cov-2
acute respiratory distress syndrome
gimsilumab
elink
Publication Type:
Article
Unique ID:
10.1164/rccm.202108-1859OC
PMID:
35290169
DOI:
10.1164/rccm.202108-1859OC
Journal:
American Journal of Respiratory and Critical Care Medicine
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View PubMed Record

Record Created: